LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 51 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,369,249 | -19.6% | 785,836 | +6.1% | 0.00% | – |
| Q2 2023 | $5,436,025 | +4571.0% | 740,603 | +2451.9% | 0.00% | – |
| Q1 2023 | $116,378 | +82.9% | 29,022 | +48.7% | 0.00% | – |
| Q4 2022 | $63,635 | -9.1% | 19,520 | +3.3% | 0.00% | – |
| Q3 2022 | $70,000 | +4.5% | 18,897 | -13.0% | 0.00% | – |
| Q2 2022 | $67,000 | -59.1% | 21,731 | -29.1% | 0.00% | – |
| Q1 2022 | $164,000 | +84.3% | 30,669 | +69.5% | 0.00% | – |
| Q4 2021 | $89,000 | -42.9% | 18,093 | +2.7% | 0.00% | – |
| Q3 2021 | $156,000 | -4.9% | 17,623 | -2.1% | 0.00% | – |
| Q2 2021 | $164,000 | – | 17,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |